Dori Healey — Representative Healey is referenced as a co-sponsor or collaborator on the bill.
Dori Healey — Representative Healey first asked to add to the discussion with a light joke about moving Representative Tanner aside, then continued with a substantive point that prior authorizations, while important for preventing incorrect prescribing or referrals, can be very time-consuming and overwhelming for providers, taking hours each day and contributing to the burden on clinicians who might otherwise precept more students.
Dori Healey — Likely refers to Vice Chair Dori Healey? The transcript says Vice Chair Erickson; context suggests a chair title but the name is uncertain.
Robert Beiswenger — Representative Beiswenger asked who determines whether a medically appropriate generic equivalent exists, and Representative Cannon responded to that question in the same exchange.
Robert Beiswenger — Representative Beiswenger said he appreciated the bill but struggled with more government involvement in health care costs.
Robert Beiswenger — Representative Beiswenger said he has long been involved in charitable efforts to help people pay health insurance, but he remains skeptical of more government involvement.
Robert Beiswenger — The speaker echoed Representative Beiswenger's earlier point about government involvement in health care costs.
Robert Beiswenger — Representative Beiswenger is called during the roll call and votes no.
Robert Beiswenger — Representative Beiswenger is called again during the roll call and votes no.
Brandon Shippy — Representative Cannon responded to a series of questions about how the bill would work in practice. He said disputes over coverage determinations would likely start between the insurance company and the patient, with pharmacists potentially having some role in determining what medication is needed. He then clarified that he did not understand the concern about 'diverting' and framed the legislation as an accounting issue for health insurers. In response to concerns about coupon inducements, he agreed pharmaceutical companies may use coupons to steer use of their products, acknowledged that coupons could theoretically encourage use of a drug that later becomes more expensive, and said he had reservations about the issue because free-market choice depends on a level playing field and consumers often do not knowingly choose plans with copay accumulators.
Brandon Shippy — Representative Furman spoke in support of the policy change, arguing it was needed and noting that many states had already adopted it, then yielded time to Representative Cannon. Cannon thanked the committee and co-sponsor Furman, and the discussion later returned to thanking Furman and Cannon for bringing the legislation forward.
Brandon Shippy — Representative Wheeler is referenced as part of the ongoing bill discussion focused on prior authorization and the burdens it places on providers; the mention is indirect and not central, but it remains within the same narrative thread.
Steven Tanner — Representative Tanner questioned the handout language about co-pay assistance, asking where the funds would be diverted and clarifying that the cited language appears in the handout rather than the bill itself.
Steven Tanner — Referenced as part of the discussion being followed up on.
Steven Tanner — Representative Tanner asked whether the bill might prompt insurers to increase deductibles or out-of-pocket maximums, drawing an analogy to how student loan policy can affect tuition. He was then directly addressed in the response to that concern.
Steven Tanner — Representative Tanner says he is conflicted about the bill and appreciates Representatives Furman and Cannon for bringing it.
Steven Tanner — Representative Tanner is called during the roll call and votes no.
Steven Tanner — Expressed confusion about the prior authorization exemption and questioned the incentive structure.
Steven Tanner — Referenced in a lighthearted exchange about making room for Representative Healey to speak.
Marco Erickson — Representative Kaler raised a free-market objection to the bill, arguing that if an employer and employee voluntarily agree to an insurance plan that excludes third-party payments in exchange for lower monthly premiums, the Idaho Legislature should not have the power to override that private contract.
Marco Erickson — Vice Chairman Erickson votes aye in the roll call.
Marco Erickson — Representative Marco Erickson introduced himself and presented House Bill 723, explaining that it adds sections to the code to improve oversight and protect youth in care facilities. He described the bill as a response to incidents where children were isolated, unable to get help, and traumatized, and said it is intended to prevent similar harm in the future. In response to questions, he explained that the bill does not create a new ombudsman because of cost, does not add a new private right of action, and instead relies on existing reporting, investigation, child protection, law enforcement, and state department processes. He also clarified that violations of the Youth Bill of Rights can be reported and may lead to corrective action, that the Department of Health and Welfare serves as legal guardian for youth in foster care, and that the bill does not create new rights but rather spells out existing rights so parents and youth know how to respond when violations occur.
Marco Erickson — The chair asked Representative Erickson to carry the bill on the floor, indicating he would handle the floor presentation.
Faye Thompson — Representative Thompson is involved in a discussion about coupon eligibility, specifically questioning whether people without insurance are eligible for the coupons. The exchange continues with follow-up reference to Thompson’s point, keeping the focus on the same eligibility issue.
Faye Thompson — Representative Faye Thompson objects to the bill, arguing that Medicaid and Medicare patients are not eligible for the coupons and that the measure is unfair, and she later votes no during the roll call.
Tiffany Meekum — Tiffany Meekum, an Idaho resident and health care administrator, introduced herself and then testified in support of House Bill 713, drawing on her personal connection to ovarian cancer in her family.
Liesel Drollinger — Liesel Drollinger testified about her family's struggles paying for a child's expensive medications and navigating insurance coverage. She explained that they use generics when available, but name-brand medications can require prior authorization and may be denied if a generic exists. She also described switching insurance after being told the new plan did not have a copay accumulator, only to later learn it did, and said the family ended up meeting deductibles they believed had already been satisfied. Overall, she said the family pays these costs and wants those expenses to count toward their coverage.
Josh Wheeler — Representative Wheeler asked Ms. Drollinger a series of related follow-up questions about how the bill would affect her family, including how their assistance and deductible situation works and whether generics have helped the family over time, emphasizing the long-term impact on her family.
Josh Wheeler — Representative Wheeler is introduced as the next speaker and then makes the motion, thanking the chair, committee, the Drollinger family, and his co-sponsor Representative Furman while explaining his support for advancing the bill.
Josh Wheeler — Representative Wheeler is called during the roll call and votes aye.
Josh Wheeler — Representative Josh Wheeler introduces himself as representing District 35 and several counties.
Josh Wheeler — Presented House Bill 655 and explained the preceptorship incentive proposal.
Josh Wheeler — Explained the pilot-program structure, specialty limits, and provider caps.
Josh Wheeler — Explained the RS changes and requested a motion to hold the bill and advance the RS.
Josh Wheeler — Restated the purpose of the RS and the request to hold the bill and advance the RS.
Josh Wheeler — Closed his overview and repeated the request for committee action.
Josh Wheeler — His bill and RS were the subject of the procedural question.
Josh Wheeler — Identified himself again and requested a motion on RS 33527.
Josh Wheeler — Was asked to explain the cap in the RS.
Josh Wheeler — Explained that the cap was intended to keep the program contained and allow future review.
Josh Wheeler — Explained that the original bill applied only to physicians and the RS broadens it to physician assistants and advanced practice providers.
Josh Wheeler — Was asked to explain the prior authorization exemption incentive.
Josh Wheeler — Explained that the exemption is meant to reduce burdensome prior authorization requirements and free up provider time.
Josh Wheeler — Expanded on the rationale for the exemption and the decision to seek a different incentive structure.
Josh Wheeler — Explained why the committee chose a different incentive approach than direct payment to doctors.
Josh Wheeler — Said the proposal uses a different incentive approach and cited provider feedback supporting it.
Josh Wheeler — Said providers reported they could take more medical students if prior authorization burden were removed.
Josh Wheeler — Referenced as the point of comparison regarding precepting and administrative burden.
Josh Wheeler — His point about preceptorship and rural retention is referenced while discussing the value of reducing administrative burden.
Josh Wheeler — Asked about the scope of the proposal as it relates to Medicaid and the private sector.